Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 28:28:100928.
doi: 10.1016/j.conctc.2022.100928. eCollection 2022 Aug.

The clinical efficiency of transcriptome-based endometrial receptivity assessment (Tb-ERA) in Chinese patients with recurrent implantation failure (RIF): A study protocol for a prospective randomized controlled trial

Wen-Bi Zhang  1 , He Li  1 , Xiang Lu  1 , Jun-Ling Chen  1 , Lu Li  1 , Jiu-Cheng Chen  2 , Han Wu  2 , Xiao-Xi Sun  1   3
Affiliations

The clinical efficiency of transcriptome-based endometrial receptivity assessment (Tb-ERA) in Chinese patients with recurrent implantation failure (RIF): A study protocol for a prospective randomized controlled trial

Wen-Bi Zhang et al. Contemp Clin Trials Commun. .

Abstract

Background: Today, approximately 10% of participants in assisted reproductive technology (ART) are defined as having recurrent implantation failure (RIF). Recent studies show that endometrial receptivity array can improve pregnancy and implantation rates by nearly 20% in women with RIF. However, these studies are limited, with little published data in the Chinese population. Recently, we have established a transcriptome-based endometrial receptivity assessment (Tb-ERA) method of predicting the endometrial window of implantation (WOI) using transcriptome-profiling data of different phases of the menstrual cycle from healthy fertile Chinese women by RNA-Seq. It is meaningful to conduct a randomized controlled trial (RCT) to assess the clinical efficiency of Tb-ERA in Chinese patients with RIF.

Methods: In this RCT, a total of 200 RIF patients will be recruited and randomized into 2 groups. Patients in the Tb-ERA group will undergo a Tb-ERA test, after which embryo transfer time will be adjusted according to Tb-ERA results and embryo transfer will be performed again in the next cycle. Patients in the control group will not receive any interventions until the next transfer cycle. We will perform statistical analysis on both groups at the primary endpoint (clinical-pregnancy rate) and at secondary endpoints (rate of WOI displacement, embryo implantation, biochemical pregnancy, early abortion, and ectopic pregnancy). Implications: This study aims to evaluate the effectiveness of our Tb-ERA test in Chinese RIF patients and to determine that whether Tb-ERA could improve the clinical-pregnancy rate in these RIF patients.

Trial registration: NCT04497558, registered August 4, 2020.

Keywords: Endometrial receptivity; Endometrial receptivity assessment; Recurrent implantation failure; Window of implantation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart of the trial design Tb-ERA, transciptome based endometrial receptivity assessment.
See this image and copyright information in PMC

References

    1. Simon A., Laufer N. Repeated implantation failure: clinical approach. Fertil. Steril. 2012;97:1039–1043. - PubMed
    1. Coughlan C., Ledger W., Wang Q., Liu F.H., Demirol A., Gurgan T., Cutting R., Ong K., Sallam H., Li T.C. Recurrent implantation failure: definition and management. Reprod. Biomed. Online. 2014;28:14–38. - PubMed
    1. Zohni K.M., Gat I., Librach C. Recurrent implantation failure: a comprehensive review. Minerva Ginecol. 2016;68:653–667. - PubMed
    1. Zeyneloglu H.B., Onalan G. Remedies for recurrent implantation failure. Semin. Reprod. Med. 2014;32:297–305. - PubMed
    1. Penzias A.S. Recurrent IVF failure: other factors. Fertil. Steril. 2012;97:1033–1038. - PubMed

Associated data